Recombinant Human Pannexin-3 (PANX3)

What is the structure and function of Pannexin-3?

Pannexin-3 (PANX3) is a 43 kDa channel-forming glycoprotein that belongs to the pannexin family discovered due to their homology with invertebrate gap junction proteins called innexins . The full-length human PANX3 protein consists of 392 amino acids (Met1-Pro392) and functions primarily as a membrane channel . PANX3 can form channels at both the cell surface and in intracellular compartments like the endoplasmic reticulum (ER), where it serves distinct functions:

• At the cell surface: Acts as a conduit for ATP release into extracellular space

• In the ER: Functions as a calcium leak channel, facilitating calcium release

Unlike true gap junction proteins, PANX3 primarily forms single membrane channels rather than intercellular channels, contributing to purinergic signaling pathways through regulated ATP release.

How is PANX3 expression regulated during cell differentiation?

PANX3 expression is temporally regulated during cell differentiation, particularly in the musculoskeletal system. In developing growth plates, Panx3 mRNA is expressed in the prehypertrophic zone and is induced during the differentiation of chondrogenic cell lines such as ATDC5 and N1511 .

Research findings demonstrate that PANX3 serves as a molecular switch that transitions cells from proliferation to differentiation:

• In chondrocytes: PANX3 is expressed in pre-hypertrophic chondrocytes and upregulated during differentiation

• In osteoblasts: PANX3 regulates the balance between proliferation and terminal differentiation

• In keratinocytes: PANX3 activation leads to NFATc1 activation, Epfn expression, and differentiation

Experimental evidence shows that PANX3 transfection into ATDC5 cells promotes chondrogenic differentiation, while suppression of endogenous PANX3 inhibits differentiation in both cell lines and primary chondrocytes .

Which tissues express PANX3 and what are appropriate controls for expression studies?

PANX3 has been detected in a diverse range of tissues beyond its initially reported localization in cartilage, bone, and skin. Current research confirms PANX3 expression in:

For appropriate controls in expression studies, researchers should consider:

• Using Panx3 knockout (KO) mouse tissues as negative controls when available

• Employing multiple antibodies targeting different epitopes of PANX3 to confirm specificity

• Validating antibody specificity due to potential cross-reactivity issues with other proteins

Note that researchers should be aware that many PANX3-expressing tissues also express PANX1, which may complicate the interpretation of purinergic signaling experiments unless specific inhibitors or gene knockdown approaches are used .

What are the optimal methods for producing and purifying recombinant human PANX3?

Successful production of recombinant human PANX3 has been achieved using several expression systems, each with specific advantages for different research applications:

For prokaryotic expression, the full-length human PANX3 (Met1-Pro392) can be expressed with N-terminal His and GST tags, resulting in high purity (>90%) suitable for multiple applications . When post-translational modifications are critical, mammalian expression in HEK-293 cells is recommended.

Purification typically involves:

• Affinity chromatography using the appropriate tag (His, GST, or Strep)

• Size exclusion chromatography for higher purity

• Quality control using SDS-PAGE, Western blotting, and analytical SEC (HPLC)

What are validated methods to assess PANX3 channel function in experimental settings?

Several complementary methods have been validated to assess PANX3 channel function:

ATP Release Assay:
PANX3 functions as an ATP release channel at the cell surface. Researchers can measure extracellular ATP concentration following stimulation of PANX3-expressing cells . This approach has successfully demonstrated that PANX3-transfected ATDC5 cells release more ATP than control cells .

Dye Uptake Assays:
Sulforhodamine B and ethidium bromide (Etd) uptake assays can evaluate PANX3 channel opening. Both PANX3-expressing rat epidermal keratinocytes (REKs) and human embryonic kidney 293T cells showed sulforhodamine B dye uptake after mechanical stimulation, indicating PANX3 functions as a mechanosensitive channel .

Calcium Imaging:
Since PANX3 in the ER functions as a calcium leak channel, calcium imaging using fluorescent indicators can assess intracellular calcium dynamics in cells expressing PANX3 .

Electrophysiology:
Patch-clamp recordings can directly measure PANX3 channel activity, though this approach is technically challenging and less commonly reported in the literature.

Specific Inhibitors and Controls:

• Anti-PANX3 antibody (specific to the first extracellular loop) can block channel function

• PANX3 inhibitory peptide ('I-peptide') can inhibit channel activity

• 10Panx mimetic peptide (used for PANX1) might have cross-reactivity with PANX3

What are recommended protocols for PANX3 detection in Western blot and immunohistochemistry?

Western Blot Protocol:

• Sample Preparation:

  • Lyse cells/tissues in buffer containing protease inhibitors

  • For membrane proteins like PANX3, include detergents like Triton X-100 or NP-40

• SDS-PAGE Conditions:

  • 10-12% polyacrylamide gels are suitable for resolving the 43 kDa PANX3 protein

  • Load 20-50 μg of total protein per lane

• Transfer and Antibody Incubation:

  • Transfer to PVDF or nitrocellulose membranes

  • Block with 5% non-fat milk or BSA

  • Incubate with validated anti-PANX3 antibodies (1:1000 dilution):

    • Rabbit anti-Panx3 (433,270 ThermoFisher) has been validated

  • Use HRP-linked secondary antibodies (1:5000 dilution)

• Controls:

  • Positive control: Recombinant PANX3 protein (e.g., ABIN7423045)

  • Negative control: Tissue from Panx3 KO mice

  • Loading control: β-Tubulin, GAPDH

Immunohistochemistry/Immunofluorescence:

• Tissue Preparation:

  • Fix tissues in 4% paraformaldehyde

  • For paraffin sections: use antigen retrieval (citrate buffer, pH 6.0)

• Staining Protocol:

  • Block with serum matching the secondary antibody species

  • Incubate with primary anti-PANX3 antibody (1:200-1:500 dilution)

  • Use fluorescent or HRP-conjugated secondary antibodies

• Validation:

  • Always include tissues from Panx3 KO mice as negative controls

  • Be aware that some commercial antibodies may detect additional immunoreactive species

How does PANX3 regulate the balance between cell proliferation and differentiation?

PANX3 serves as a critical molecular switch that regulates the transition from cell proliferation to differentiation through multiple mechanisms:

ATP Release and Purinergic Signaling:
PANX3 channels at the cell surface release ATP into the extracellular space, which activates P2 receptors, triggers calcium signaling, and initiates differentiation pathways . In chondrocytes, PANX3-mediated ATP release reduces intracellular cAMP levels and inhibits protein kinase A (PKA) activity, leading to decreased proliferation and enhanced differentiation .

Inhibition of Proliferative Signaling:
PANX3 expression in chondrogenic cells reduces parathyroid hormone (PTH)-induced cell proliferation by inhibiting cAMP response element-binding protein (CREB) activation, a key downstream effector of PKA . This mechanism directly counteracts proliferative signals:

Calcium Signaling:
PANX3 in the endoplasmic reticulum functions as a calcium leak channel, increasing cytosolic calcium levels. This triggers calcineurin activation, which dephosphorylates and activates transcription factors like NFATc1 that promote differentiation .

Tissue-Specific Mechanisms:

• In chondrocytes: PANX3 expression induces markers including aggrecan, collagen type X α1 and II α1, and cartilage proteoglycans

• In osteoblasts: PANX3 promotes alkaline phosphatase activity and matrix mineralization

• In keratinocytes: PANX3 activates NFATc1, induces Epfn expression, and promotes terminal differentiation

What are the mechanisms of PANX3 channel activation in different cellular contexts?

PANX3 channels can be activated through multiple mechanisms depending on the cellular context:

1. Membrane Depolarization:
Like other pannexins, PANX3 channels may open in response to changes in membrane potential, though this mechanism is less well-characterized for PANX3 than for PANX1 .

2. Small Molecule Stimulation:
Several molecules can trigger PANX3 channel opening:

• Fatty acids: Palmitate stimulates PANX3 channel opening and ATP release in myotubes through the toll-like receptor 4-myeloid differentiation factor-88/nuclear factor-κB (NF-κB) pathway

• Cytokines: In PANX3-overexpressing HaCaT cells, TGF-β and TNF-α stimulation increased ATP release compared to vector controls

• ATP itself: Exogenous ATP application to PANX3-expressing cells can increase intracellular calcium, suggesting a potential positive feedback mechanism

3. Mechanical Stimulation:
PANX3 acts as a mechanosensitive channel in multiple cell types:

• Both PANX3-expressing rat epidermal keratinocytes (REKs) and human embryonic kidney 293T cells showed sulforhodamine B dye uptake after mechanical stimulation

• This mechanical sensitivity may be particularly relevant in tissues like bone and cartilage that experience significant mechanical forces

4. Differentiation Signals:
PANX3 channel activity increases during differentiation in multiple cell types. In chondrocytes, PANX3 channel opening can be blocked by an anti-PANX3 antibody specific to the first extracellular loop or by the PANX3 inhibitory peptide ('I-peptide') .

It's important to note that many of these activation mechanisms have been characterized in overexpression systems, which may not fully recapitulate endogenous PANX3 regulation .

How do PANX3 and PANX1 channels differ in function and inhibitor sensitivity?

While PANX3 and PANX1 belong to the same protein family and share structural similarities, they exhibit important differences in expression patterns, functions, and pharmacological properties:

Inhibitor Sensitivity:

• Antibodies: Anti-PANX3 antibody specific to the first extracellular loop can block PANX3 function but not PANX1

• Inhibitory peptides: PANX3 inhibitory peptide ('I-peptide') specifically blocks PANX3 channels

• 10Panx mimetic peptide: Designed to inhibit PANX1, but may have cross-reactivity with PANX3 in some contexts

• Probenecid: Inhibits PANX1 channels, but its effect on PANX3 is less characterized

• Carbenoxolone: Inhibits both PANX1 and PANX3, but with different potencies

Since many tissues co-express PANX1 and PANX3, researchers should carefully design experiments with appropriate controls to distinguish their functions, potentially using genetic approaches (siRNA, CRISPR) alongside pharmacological tools .

What role does PANX3 play in bone and cartilage development and disease?

PANX3 serves critical functions in the development, homeostasis, and pathology of skeletal tissues:

Cartilage Development:
PANX3 is expressed in the prehypertrophic zone of the developing growth plate and regulates the transition from proliferative to hypertrophic chondrocytes . During endochondral ossification, PANX3:

• Promotes the expression of chondrocyte differentiation markers (aggrecan, collagen type X α1 and II α1)

• Reduces PTH-induced proliferation by inhibiting cAMP signaling

• Facilitates ATP release that triggers differentiation pathways

Bone Formation:
In osteoblasts, PANX3 functions through similar mechanisms as in chondrocytes, regulating the balance between proliferation and differentiation . PANX3 promotes:

• Alkaline phosphatase activity

• Matrix mineralization

• Terminal osteoblast differentiation

Osteoarthritis and Joint Disease:
PANX3's role in osteoarthritis appears context-dependent:

• In age-related osteoarthritis: PANX3 may play a protective role by maintaining chondrocyte differentiation

• In injury-induced osteoarthritis: PANX3 activation might contribute to pathological changes

Intervertebral Disc Degeneration:
PANX3 expression has been reported in intervertebral discs, with potential implications for disc degeneration and associated back pain .

PANX3 knockout mouse models have been instrumental in elucidating these functions, demonstrating skeletal abnormalities that underscore PANX3's importance in proper bone and cartilage development .

How can researchers use PANX3 in cell motility and migration studies?

PANX3 plays important roles in cell motility and migration, making it a valuable target for researchers studying these processes in contexts such as wound healing, development, and cancer:

Experimental Approaches for Studying PANX3 in Cell Migration:

• In Vitro Scratch Wound Assay:

  • Create a scratch in a confluent monolayer of cells expressing PANX3

  • Monitor wound closure over time (e.g., every 2 hours for 24 hours)

  • Compare closure rates between:

    • Cells with endogenous PANX3 expression

    • Cells treated with PANX3 inhibitors (10Panx mimetic peptide)

    • Cells with PANX3 knockdown via siRNA

• Single-Cell Motility Assay:

  • Track individual cell movements over time using time-lapse microscopy

  • Calculate motility parameters such as velocity, directionality, and persistence

  • Compare PANX3-expressing cells with controls

• PANX3 Knockdown:

  • Use siRNA to reduce PANX3 expression and assess effects on migration

  • Validate knockdown efficiency using Western blot or RT-PCR

• ATP Measurement:

  • Quantify ATP release during migration using luminescence-based assays

  • Correlate ATP levels with migration rates and PANX3 expression/activity

• Purinergic Signaling Analysis:

  • Investigate P2 receptor involvement using specific antagonists

  • Assess downstream calcium signaling pathways

These approaches can be particularly valuable in studying fibroblast migration during wound healing, where PANX3 channels and purinergic signaling play significant roles .

What is the evidence for PANX3 involvement in cancer and other diseases?

Emerging evidence implicates PANX3 in various pathological conditions:

Cancer:

• Osteosarcoma: Altered PANX3 expression has been observed, potentially related to its role in osteoblast differentiation

• Non-melanoma skin cancer: PANX3 expression changes have been reported, suggesting a role in keratinocyte differentiation and skin homeostasis

The exact mechanisms behind PANX3's involvement in cancer remain under investigation, but likely involve its functions in:

• Regulating cell proliferation

• Controlling differentiation status

• Mediating ATP release and purinergic signaling

• Modulating calcium homeostasis

Metabolic Disorders:

• Obesity: PANX3 has been implicated in obesity-related inflammation, particularly in skeletal muscle

• In myotubes, palmitate stimulates PANX3 channel opening and ATP release, which acts as a monocyte chemoattractant in vitro through the toll-like receptor 4-myeloid differentiation factor-88/nuclear factor-κB (NF-κB) pathway

Neuromuscular Disorders:

• Duchenne's muscular dystrophy: Altered PANX3 expression has been observed, though the functional significance remains unclear

Development and Aging:
PANX3 levels are temporally regulated in tissues such as skeletal muscle, skin, and the cochlea, suggesting potential roles in developmental disorders and age-related conditions .

Most findings on PANX3's role in disease have come from characterization of Panx3 knockout mouse models, highlighting the importance of these tools in understanding PANX3 biology .

What are optimal storage and handling conditions for recombinant PANX3 protein?

Proper storage and handling of recombinant PANX3 protein is essential for maintaining its stability and functionality in research applications:

Storage Conditions:

• Short-term storage (up to one month): 2-8°C (refrigeration)

• Long-term storage: -80°C in aliquots to minimize freeze-thaw cycles

• Lyophilized protein shows greater stability than solutions

Buffer Composition:
The optimal buffer for recombinant PANX3 typically contains:

• PBS, pH 7.4

• 0.01% SKL (stabilizer)

• 1 mM DTT (reducing agent to maintain protein structure)

• 5% Trehalose (cryoprotectant)

• Proclin300 (preservative)

Reconstitution Protocol:

• Allow the lyophilized protein to reach room temperature before opening

• Reconstitute in sterile water or buffer to desired concentration

• Gently mix by inversion, avoiding vigorous shaking that could denature the protein

• Aliquot the reconstituted protein to minimize freeze-thaw cycles

Handling Precautions:

• Avoid repeated freeze-thaw cycles, which can significantly reduce protein activity

• Note that the preservative ProClin is classified as a hazardous substance and should be handled by trained staff only

• For optimal working dilution, researchers should perform titration experiments to determine the ideal concentration for specific applications

Quality Control Indicators:

• Purity: >90% for prokaryotic expression systems (E. coli)

• Expect a band at approximately 43 kDa on SDS-PAGE gels, though the apparent molecular weight may vary depending on post-translational modifications

How can recombinant PANX3 be used to develop and validate PANX3-specific antibodies and inhibitors?

Recombinant PANX3 protein serves as a valuable tool for developing and validating PANX3-specific antibodies and inhibitors:

Antibody Development:

• Immunization Strategy:

  • Use purified recombinant PANX3 (ABIN7423045) as an immunogen

  • Target specific domains like the extracellular loops for function-blocking antibodies

  • Consider post-translational modifications when selecting expression systems

• Antibody Validation:

  • Use recombinant PANX3 as a positive control in Western blots

  • Perform peptide competition assays to confirm specificity

  • Test antibodies in tissues from Panx3 KO mice to assess specificity

  • Check for cross-reactivity with PANX1 and PANX2

• Epitope Mapping:

  • Use domain-specific recombinant proteins to identify antibody binding sites

  • This information is crucial for developing function-blocking antibodies

Inhibitor Development and Validation:

• Screen for PANX3-Specific Inhibitors:

  • Use recombinant PANX3 in binding assays to identify potential inhibitors

  • Test candidate molecules in dye uptake or ATP release assays using PANX3-expressing cells

• Validate Specificity:

  • Compare effects on PANX3 versus PANX1 channels

  • Assess effects of inhibitors on cells transfected with recombinant PANX3 versus controls

  • Test inhibitors on functional assays like the PANX3-mediated ATP release

• Structure-Activity Relationship Studies:

  • Use recombinant PANX3 for crystallography or structural studies

  • Design rational inhibitors based on structural information

Current research uses several approaches to block PANX3 function, including:

• Anti-PANX3 antibody specific to the first extracellular loop

• PANX3 inhibitory peptide ('I-peptide')

• 10Panx mimetic peptide (though this may have cross-reactivity with PANX1)

What are effective experimental designs for studying PANX3 signaling pathways using recombinant protein?

Researchers can employ several experimental designs to investigate PANX3 signaling pathways using recombinant protein:

Reconstituted Liposome Systems:

• Incorporate purified recombinant PANX3 into liposomes

• Measure ATP release or dye uptake in response to various stimuli

• Analyze channel kinetics and pharmacology in a controlled system

• Advantage: Isolates PANX3 function from other cellular components

Cell-Based Overexpression Systems:

• Transfect cells with recombinant PANX3 expression vectors

• Compare wild-type PANX3 with mutated variants

• Assess effects on:

  • ATP release (using luminescence-based assays)

  • Intracellular cAMP levels

  • CREB phosphorylation

  • Calcium dynamics

  • Differentiation markers

• Advantage: Allows study of PANX3 in cellular context

Pull-Down and Interaction Studies:

• Use tagged recombinant PANX3 (His-tag, GST-tag) for pull-down experiments

• Identify PANX3 binding partners in various cell types

• Validate interactions using co-immunoprecipitation

• Map interaction domains using truncated PANX3 variants

• Advantage: Reveals molecular mechanisms of PANX3 function

Pathway Analysis Experiments:
The following experimental design has been effective for studying PANX3 signaling in chondrocytes:

This experimental design has revealed that PANX3 inhibits PTH-induced cell proliferation by promoting ATP release, which reduces intracellular cAMP levels and inhibits CREB activation .

For all these approaches, appropriate controls are essential, including:

• Cells expressing empty vectors

• PANX3 with inactivating mutations

• Treatment with PANX3-specific inhibitors

• Parallel experiments in cells with PANX3 knockdown

Human Recombinant PANX3 protein (ABIN7423045) with >90% purity serves as an excellent tool for these experimental designs .

What are the most promising future research directions for PANX3?

Recent advances in PANX3 research have opened several promising avenues for future investigation:

• Structural Biology:

  • Determine the crystal structure of PANX3 channels to enable rational drug design

  • Investigate conformational changes during channel opening/closing

  • Compare structural features with PANX1 and PANX2 to identify family-specific characteristics

• Cell-Type Specific Functions:

  • Explore PANX3 roles in newly identified expressing tissues

  • Investigate tissue-specific binding partners and regulators

  • Develop conditional knockout models to address developmental roles

• Disease Mechanisms:

  • Further investigate PANX3 contributions to osteoarthritis progression or protection

  • Explore potential roles in metabolic disorders and inflammation

  • Assess PANX3 as a therapeutic target in bone and cartilage diseases

• Signaling Integration:

  • Map the complete signaling networks connecting PANX3 to differentiation pathways

  • Investigate crosstalk between PANX3 and other membrane channels/receptors

  • Explore how mechanical forces are transduced through PANX3 channels

• Therapeutic Applications:

  • Develop PANX3-specific modulators (activators or inhibitors)

  • Explore PANX3 as a target for promoting bone and cartilage regeneration

  • Investigate PANX3 in cancer progression and as a potential therapeutic target

Future research would benefit from improved tools, including:

• More specific antibodies and inhibitors

• Tissue-specific and inducible knockout models

• Advanced imaging techniques to visualize PANX3 dynamics in real-time

What are common methodological challenges when working with recombinant PANX3 and how can they be addressed?

Researchers face several methodological challenges when working with recombinant PANX3:

1. Protein Solubility and Stability:

• Challenge: As a membrane protein, PANX3 can be difficult to maintain in soluble, functional form

• Solution: Use appropriate detergents or lipid environments; consider protein stabilizing agents like trehalose (5%) and DTT (1 mM); store at recommended temperatures (-80°C for long-term)

2. Antibody Specificity:

• Challenge: Many commercially available antibodies show cross-reactivity or detect additional immunoreactive species

• Solution: Validate antibodies using Panx3 KO tissues; use multiple antibodies targeting different epitopes; develop monoclonal antibodies against specific PANX3 domains

3. Distinguishing PANX3 from PANX1 Functions:

• Challenge: Many tissues co-express PANX1 and PANX3, complicating functional studies

• Solution: Use specific inhibitors when available; employ genetic approaches (siRNA, CRISPR); compare tissues with differential expression of PANX1 vs. PANX3

4. Overexpression Artifacts:

• Challenge: Overexpression systems may not recapitulate endogenous trafficking and function

• Solution: Compare results from overexpression systems with endogenous expression; use inducible expression systems with titratable expression levels

5. Post-Translational Modifications:

• Challenge: E. coli-expressed recombinant PANX3 lacks mammalian post-translational modifications

• Solution: Use mammalian expression systems (HEK-293 cells) for applications where modifications are critical

6. Functional Assays Standardization:

• Challenge: Variability in ATP release and dye uptake assays between laboratories

• Solution: Develop standardized protocols; include appropriate positive and negative controls; use multiple complementary assays to confirm findings

7. Storage and Handling:

• Challenge: Protein activity loss during storage or improper handling

• Solution: Store as recommended (2-8°C for short-term, -80°C for long-term); aliquot to avoid freeze-thaw cycles; handle hazardous preservatives (ProClin) with appropriate precautions